Luis Pizarro-Otero says the moratorium could help offset the impact of the U.S.-China trade war. #NewsismyBusiness
Pharmaceutical manufacturing in Puerto Rico has been thriving for more than six decades. #NewsismyBusiness
The local sector employed 42,483 individuals in 2023, compared to 37,170 jobs in 2019. #NewsismyBusiness
The European distributor aims to expand its presence in the advanced materials markets in the Central America region. #NewsismyBusiness
For the second day this week, a delegation of White House officials hosted by Puerto Rico’s Resident Commissioner Jenniffer González toured several pharmaceuticals and aerospace companies on the island, in an effort to lure new business for the economy. The goal is to show the island’s “capacity and infrastructure to host multinationals, showing the diversity […]
Puerto Rico’s pharmaceutical manufacturing sector took a major hit from Hurricanes Irma and María in September, but are in recovery mode and back in production to ensure continuity in the availability of medications in Puerto Rico and globally, Jaime Palacios, president of the Pharmaceutical Industry Association said Wednesday.
The head of the U.S. Food and Drug Administration, Scott Gottlieb said this week the agency is “doing all it can” to support the immediate needs of Puerto Ricans after Hurricane María’s destruction, as well as ensure supplies of critical drugs produced on the island.
Is our current political status limiting our economic potential? That was the controversial question that was asked during last year’s ALPFA Puerto Rico’s marquee event, when a panel of five senior executives from the corporate, nonprofit and entrepreneurial sectors answered questions about our island’s most pressing problem: How to stop the infamous “brain drain.” It […]
Two pharmaceutical giants, Bayer AG and Merck, announced this morning a deal through which the first has agreed to pay $14.2 billion for the latter’s Consumer Care Unit, picking up global trademark and prescription rights for a number of recognized brands, including Claritin and Afrin.
It was five years ago that manufacturing giant GlaxoSmithKline North America Pharmaceuticals took a step back to assess the way it was doing business.
The Puerto Rico Pharmaceutical Industry Association will be hosting its 24th annual convention this week, when local and stateside speakers will discuss strategies that companies can apply to transform for a better future — this year’s theme.
Gov. Alejandro García-Padilla’s economic team is working on patching things up with pharmaceutical companies doing business in Puerto Rico, which they said Wednesday have “lost trust” in the island’s government.
Puerto Rico is among a select group of U.S. jurisdictions specializing in four of the five sectors that make up the thriving bioscience industry and is among a handful of states boasting a significant employment base and a specialized concentration of jobs in drugs and pharmaceuticals, according to the findings of the “Battelle/BIO State Bioscience Industry Development Report” released Wednesday.
Puerto Rico Puerto, the second largest investment destination in the region, is struggling to retain its position as a “viable value proposition” for pharmaceutical companies that have significantly scaled back their investments on the island in the last four years, a recently released study by Jones Lang LaSalle a global real estate services firm concluded.
The Puerto Rico Manufacturers Association rejected the conclusions of a study released this week language and cultural barriers among the employees in companies located in Puerto Rico and their stateside counterparts may be risk factors causing quality problems in local plants.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA